TFF Pharmaceuticals (TFFP)
(Delayed Data from NSDQ)
$2.92 USD
-0.13 (-4.21%)
Updated Apr 26, 2024 03:58 PM ET
After-Market: $2.89 -0.03 (-1.08%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for TFF Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -21.24 | -31.77 | -31.04 | -18.57 | -11.87 |
Depreciation/Amortization & Depletion | 0.50 | 0.39 | 0.11 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | 1.53 | -0.21 | -2.18 | -0.26 | 0.06 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.18 | 4.25 | 3.55 | 2.21 | 0.59 |
Net Cash From Operating Activities | -16.04 | -27.34 | -29.56 | -16.62 | -11.22 |
Property & Equipment | -0.09 | -1.55 | -0.87 | -1.10 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.09 | -1.55 | -0.87 | -1.10 | 0.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 5.12 | 11.75 | 28.88 | 24.99 | 29.05 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 5.01 | 11.75 | 28.88 | 24.99 | 29.05 |
Effect of Exchange Rate Changes | -0.01 | -0.04 | 0.03 | -0.07 | 0.00 |
Net Change In Cash & Equivalents | -11.13 | -17.18 | -1.51 | 7.21 | 17.83 |
Cash at Beginning of Period | 16.61 | 33.79 | 35.30 | 28.09 | 10.26 |
Cash at End of Period | 5.48 | 16.61 | 33.79 | 35.30 | 28.09 |
Diluted Net EPS | -11.85 | -26.50 | -31.25 | -22.75 | -132.75 |
Fiscal Year End for TFF Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -21.24 | -16.48 | -12.07 | -7.05 |
Depreciation/Amortization & Depletion | NA | 0.50 | 0.37 | 0.25 | 0.12 |
Net Change from Assets/Liabilities | NA | 1.53 | 1.16 | 0.69 | 1.09 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 3.18 | 3.12 | 2.31 | 1.47 |
Net Cash From Operating Activities | NA | -16.04 | -11.82 | -8.82 | -4.37 |
Property & Equipment | NA | -0.09 | -0.05 | -0.04 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -0.09 | -0.05 | -0.04 | 0.00 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 5.12 | 5.09 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.11 | -0.08 | -0.08 | -0.02 |
Net Cash from Financing Activities | NA | 5.01 | 5.01 | -0.08 | -0.02 |
Effect of Exchange Rate Changes | NA | -0.01 | -0.03 | -0.01 | -0.01 |
Net Change In Cash & Equivalents | NA | -11.13 | -6.89 | -8.95 | -4.40 |
Cash at Beginning of Period | NA | 16.61 | 16.61 | 16.61 | 16.61 |
Cash at End of Period | NA | 5.48 | 9.73 | 7.66 | 12.22 |
Diluted Net EPS | NA | -1.35 | -2.25 | -3.50 | -4.75 |